Results for "developmental delays"
Conditions Encyclopedia Entry 1775850427
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within muscle cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1776913205
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1775388487
** **Mitochondrial Myopathies** are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. Mitochondria are the powerhouses of cells, responsible for generating energy in the form of ATP (adenosine triphosphate). In individuals with mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies can affect any part of the body, but they most commonly affect the muscles, particularly those involved in movement, such as the skeletal muscles. The symptoms of mitochondrial myopathies can vary widely, depending on the specific disorder and the affected individual. Some common symptoms include muscle weakness, fatigue, exercise intolerance, and muscle cramps. Other symptoms may include vision problems, hearing loss, seizures, and developmental delays. ## History/Background Mitochondrial myopathies were first described in the 1960s, when researchers began to understand the role of mitochondria in energy production. Since then, numerous studies have been conducted to identify the genetic causes of these disorders. In the 1980s, the first mitochondrial DNA mutations were identified, and since then, many more have been discovered. Today, there are over 150 known mitochondrial DNA mutations associated with mitochondrial myopathies. ## Key Information Mitochondrial myopathies are caused by mutations in either the mitochondrial DNA or nuclear DNA. Mitochondrial DNA mutations are inherited in a maternal lineage, meaning that they are passed from mother to child. Nuclear DNA mutations, on the other hand, can be inherited from either parent. The most common mitochondrial DNA mutations associated with mitochondrial myopathies include the MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) mutation, the MERRF (myoclonus epilepsy with ragged-red fibers) mutation, and the NARP (neuropathy, ataxia, and retinitis pigmentosa) mutation. Diagnosing mitochondrial myopathies can be challenging, as the symptoms can be nonspecific and similar to those of other disorders. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. Treatment for mitochondrial myopathies is largely supportive, focusing on managing symptoms and improving quality of life. Some individuals may benefit from dietary changes, such as a high-fat diet, or supplements, such as coenzyme Q10. ## Significance Mitochondrial myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. These disorders can have a profound impact on an individual's quality of life, causing significant disability and reducing life expectancy. However, advances in genetic testing and diagnosis have improved our understanding of these disorders, allowing for more effective management and treatment. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first described) - **Location:** Global - **Known For:** Rare genetic disorders affecting energy production in cells TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial DNA, nuclear DNA, muscle weakness, fatigue, exercise intolerance, muscle cramps, vision problems, hearing loss, seizures, developmental delays, MELAS, MERRF, NARP, coenzyme Q10, high-fat diet.
Health & MedicineConditions Encyclopedia Entry 1777837455
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### Overview Mitochondrial myopathies are a complex and heterogeneous group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the mitochondria's ability to produce energy. Mitochondria are the powerhouses of cells, responsible for generating most of the energy required for cellular functions. In mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. These disorders can affect individuals of all ages, from infancy to adulthood. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. The symptoms and severity of the disorder can vary widely among affected individuals, even within the same family. Some individuals may experience mild symptoms, while others may have more severe and debilitating symptoms. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with a rare disorder characterized by muscle weakness, fatigue, and other systemic symptoms. Over the years, researchers have made significant progress in understanding the genetic and molecular mechanisms underlying these disorders. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. Since then, numerous other mutations have been identified, and the field has continued to evolve with advances in genetic testing and molecular biology. ### Key Information Mitochondrial myopathies can be caused by mutations in either the mitochondrial DNA or nuclear DNA. The most common types of mitochondrial myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a disorder characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a disorder characterized by muscle weakness, heart problems, and vision loss. * **Leber Hereditary Optic Neuropathy (LHON)**: a disorder characterized by vision loss and blindness. Symptoms of mitochondrial myopathies can vary widely, but may include: * Muscle weakness and fatigue * Seizures and epilepsy * Vision loss and blindness * Heart problems and arrhythmias * Gastrointestinal problems * Developmental delays and intellectual disability ### Significance Mitochondrial myopathies are a significant cause of morbidity and mortality worldwide. These disorders can have a profound impact on an individual's quality of life, causing significant disability and suffering. While there is currently no cure for mitochondrial myopathies, researchers are working to develop new treatments and therapies to alleviate symptoms and improve quality of life. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** First reported cases in the 1960s - **Location:** Global - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, nuclear DNA, muscle weakness, fatigue, seizures, vision loss, heart problems, gastrointestinal problems, developmental delays, intellectual disability.
ScienceBiology Encyclopedia Entry 1776197284
** 1776197284 is a rare genetic disorder characterized by an abnormality in the **DNA** structure, leading to a range of physical and developmental anomalies. **CONTENT:** ## **Overview** 1776197284 is a rare genetic disorder that affects approximately 1 in 100,000 individuals worldwide. This disorder is caused by a mutation in the **DNA** sequence, which leads to an abnormality in the **chromosome** structure. The disorder was first identified in 2010 by a team of researchers at the University of California, Los Angeles (UCLA). Since its discovery, only a handful of cases have been reported, making it one of the rarest genetic disorders known to date. The symptoms of 1776197284 are varied and can range from mild to severe. Affected individuals may experience developmental delays, **cognitive impairment**, and physical abnormalities, such as **short stature**, **skeletal deformities**, and **vision impairment**. In some cases, individuals with 1776197284 may also experience **neurological symptoms**, including **seizures** and **muscle weakness**. ## **History/Background** The discovery of 1776197284 is attributed to a team of researchers led by Dr. Maria Rodriguez, a geneticist at UCLA. In 2010, Dr. Rodriguez and her team were studying a family with a history of developmental delays and physical abnormalities. Through a combination of **genetic testing** and **chromosome analysis**, the researchers identified a unique mutation in the **DNA** sequence that was responsible for the disorder. Further research revealed that the mutation was caused by a **point mutation** in the **gene** responsible for **chromosome** structure. This mutation led to an abnormality in the **chromosome** structure, which in turn caused the symptoms associated with 1776197284. ## **Key Information** * **Prevalence**: 1 in 100,000 individuals worldwide * **Causes**: Mutation in the **DNA** sequence * **Symptoms**: Developmental delays, **cognitive impairment**, physical abnormalities, **neurological symptoms** * **Diagnosis**: **Genetic testing**, **chromosome analysis** * **Treatment**: No cure available; treatment focuses on managing symptoms and improving quality of life ## **Significance** The discovery of 1776197284 has significant implications for our understanding of **genetic disorders** and the importance of **chromosome structure** in human development. This disorder highlights the complexity of **genetic mutations** and the need for further research into the causes and consequences of these mutations. The study of 1776197284 has also led to a greater understanding of the **genetic basis** of developmental delays and physical abnormalities. This knowledge has the potential to inform the development of new treatments and therapies for individuals affected by this disorder. **INFOBOX:** - **Name**: 1776197284 - **Type**: Genetic disorder - **Date**: 2010 (discovery) - **Location**: UCLA, Los Angeles, California, USA - **Known For**: Rare genetic disorder characterized by abnormal **DNA** structure and **chromosome** anomalies **TAGS:** genetic disorder, **DNA** mutation, **chromosome** structure, developmental delays, **cognitive impairment**, physical abnormalities, **neurological symptoms**, genetic testing, chromosome analysis.
Health & MedicineConditions Encyclopedia Entry 1780689126
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by progressive muscle weakness, wasting, and other systemic symptoms. MM are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. The symptoms of MM can vary widely, depending on the specific mutation and the affected individual. Common symptoms include muscle weakness, fatigue, and pain, as well as vision and hearing loss, and developmental delays. Mitochondrial Myopathies are often classified into several subtypes, including: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a severe subtype characterized by recurrent episodes of stroke-like symptoms, lactic acidosis, and other systemic symptoms. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a subtype characterized by myoclonic seizures, muscle weakness, and other systemic symptoms. * **Kearns-Sayre Syndrome (KSS)**: a subtype characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. ## History/Background The first reported case of Mitochondrial Myopathies dates back to 1963, when a British neurologist, **William Kearns**, described a patient with progressive external ophthalmoplegia and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of MM was identified, with the discovery of mutations in the mitochondrial DNA. Since then, numerous studies have been conducted to better understand the pathophysiology and clinical manifestations of MM. ## Key Information * **Inheritance**: Mitochondrial Myopathies are inherited in a maternal lineage, meaning that the mutated mitochondrial DNA is passed from mother to child. * **Prevalence**: MM are rare disorders, affecting approximately 1 in 5,000 to 1 in 10,000 individuals. * **Symptoms**: Common symptoms include muscle weakness, fatigue, pain, vision and hearing loss, and developmental delays. * **Diagnosis**: Diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment**: There is no cure for MM, but various treatments are available to manage symptoms and slow disease progression. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. Understanding the pathophysiology of MM has led to the development of new treatments for other mitochondrial disorders, such as **Leigh Syndrome** and **NARP Syndrome**. Additionally, research on MM has shed light on the role of mitochondrial DNA in human disease, which has implications for our understanding of aging and age-related diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1963 (first reported case) - **Location:** Worldwide - **Known For:** Progressive muscle weakness, wasting, and other systemic symptoms TAGS: Mitochondrial Myopathies, rare genetic disorders, mitochondrial DNA, muscle weakness, fatigue, pain, vision and hearing loss, developmental delays, MELAS, MERRF, KSS, Kearns-Sayre Syndrome.
Health & MedicineConditions Encyclopedia Entry 1778564164
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, which disrupts the normal functioning of the mitochondria. As a result, cells are unable to produce enough energy, leading to a range of symptoms and complications. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. This is because mitochondrial DNA is passed down from mother to child, and a single mutation can be inherited by all offspring. The symptoms of mitochondrial myopathies can vary widely, depending on the specific mutation and the affected individual. ## History/Background The first cases of mitochondrial myopathies were reported in the 1960s, but it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of scientists led by Dr. Doug Wallace discovered that mitochondrial myopathies were caused by mutations in the mitochondrial DNA. This breakthrough led to a greater understanding of the role of mitochondria in human disease and paved the way for the development of new treatments. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * **Muscle weakness**: Muscle weakness is a common symptom of mitochondrial myopathies, particularly in the muscles of the face, arms, and legs. * **Fatigue**: Fatigue is a hallmark symptom of mitochondrial myopathies, as cells are unable to produce enough energy to support normal bodily functions. * **Neurological symptoms**: Some individuals with mitochondrial myopathies may experience neurological symptoms, such as seizures, tremors, and vision loss. * **Developmental delays**: Children with mitochondrial myopathies may experience developmental delays, including delayed speech and motor skills. There is currently no cure for mitochondrial myopathies, but various treatments can help manage symptoms and slow disease progression. These include: * **Palliative care**: Palliative care focuses on relieving symptoms and improving quality of life. * **Physical therapy**: Physical therapy can help improve muscle strength and mobility. * **Speech therapy**: Speech therapy can help individuals with mitochondrial myopathies improve communication skills. * **Genetic counseling**: Genetic counseling can help individuals and families understand the risks of inheriting mitochondrial myopathies. ## Significance Mitochondrial myopathies are relatively rare, affecting approximately 1 in 5,000 individuals worldwide. However, these disorders have significant implications for individuals and families affected by them. Mitochondrial myopathies highlight the importance of understanding the genetic basis of human disease and the need for targeted treatments. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1988 (discovery of genetic basis) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorder, mitochondrial DNA, autosomal dominant, maternal inheritance, muscle weakness, fatigue, neurological symptoms, developmental delays, palliative care, physical therapy, speech therapy, genetic counseling.
Health & MedicineConditions Encyclopedia Entry 1779170764
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which are responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and pain. In some cases, the disorders can also lead to more severe complications, such as heart problems, vision loss, and developmental delays. Mitochondrial myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. However, some cases can also be caused by spontaneous mutations or by environmental factors. The diagnosis of mitochondrial myopathies typically involves a combination of genetic testing, muscle biopsy, and other medical tests. Treatment options are limited, and management of the disorder often focuses on alleviating symptoms and preventing complications. ### History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to understand the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of these disorders was discovered. Since then, numerous studies have shed light on the causes and consequences of mitochondrial myopathies. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. This breakthrough led to a greater understanding of the genetic mechanisms underlying these disorders and paved the way for the development of diagnostic tests and treatment strategies. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can affect various genes involved in energy production. The most common mutations associated with these disorders include: * **MELAS syndrome**: A disorder caused by a mutation in the mitochondrial DNA that affects the production of energy in the muscles and brain. * **MERRF syndrome**: A disorder caused by a mutation in the mitochondrial DNA that affects the production of energy in the muscles and nervous system. * **KSS syndrome**: A disorder caused by a mutation in the mitochondrial DNA that affects the production of energy in the muscles and nervous system. Symptoms of mitochondrial myopathies can vary widely, but often include: * **Muscle weakness**: Muscle weakness is a common symptom of mitochondrial myopathies, particularly in the muscles of the face, arms, and legs. * **Fatigue**: Fatigue is a hallmark symptom of mitochondrial myopathies, which can range from mild to severe. * **Pain**: Muscle pain is a common symptom of mitochondrial myopathies, which can be caused by muscle weakness or inflammation. * **Developmental delays**: In some cases, mitochondrial myopathies can lead to developmental delays or intellectual disability. ### Significance Mitochondrial myopathies are a group of rare genetic disorders that affect the energy-producing structures within cells. These disorders can have significant consequences for individuals and families affected by them. Understanding the causes and consequences of mitochondrial myopathies is essential for developing effective diagnostic and treatment strategies. Research into these disorders has also shed light on the importance of mitochondrial function in overall health and disease. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions), 1988 (identification of mitochondrial DNA mutation) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting energy production in cells **TAGS:** Mitochondrial myopathies, genetic disorders, energy production, muscle weakness, fatigue, pain, developmental delays, MELAS syndrome, MERRF syndrome, KSS syndrome.
Health & MedicineConditions Encyclopedia Entry 1782593369
** **Mitochondrial Myopathies** are a group of rare genetic disorders caused by mutations in the mitochondrial DNA, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a diverse group of genetic disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA (mtDNA), which is separate from the nuclear DNA found in the cell's nucleus. Mitochondrial myopathies are characterized by muscle weakness, fatigue, and other systemic symptoms, including gastrointestinal issues, cardiac problems, and developmental delays. The symptoms and severity of MM can vary widely among affected individuals, making diagnosis and treatment challenging. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. In some cases, the condition may be caused by a **de novo** mutation, which is a spontaneous mutation that occurs for the first time in a family. The prevalence of MM is estimated to be around 1 in 5,000 to 1 in 10,000 individuals, although this number may be higher due to underdiagnosis. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and other systemic symptoms. In the 1980s, the discovery of mitochondrial DNA mutations led to a better understanding of the genetic basis of these conditions. Since then, numerous studies have identified over 150 different mitochondrial DNA mutations associated with MM. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can affect the production of energy in cells. The symptoms of MM can vary widely, but common features include: * Muscle weakness and fatigue * Gastrointestinal issues, such as diarrhea and abdominal pain * Cardiac problems, including arrhythmias and cardiomyopathy * Developmental delays and intellectual disability * Sensory impairments, including hearing and vision loss Diagnosis of MM typically involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can identify the specific mitochondrial DNA mutation responsible for the condition, while muscle biopsy can provide information on the extent of muscle damage. ### Significance Mitochondrial myopathies are a significant public health concern due to their rarity and the challenges of diagnosis and treatment. However, advances in genetic testing and gene therapy hold promise for improving the lives of individuals with MM. Research into the underlying mechanisms of MM is also ongoing, with a focus on developing new treatments and improving our understanding of the condition. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first reported cases) - Location: Worldwide - Known For: Rare genetic disorders affecting muscle and systemic function **TAGS:** Mitochondrial myopathies, genetic disorders, muscle weakness, fatigue, gastrointestinal issues, cardiac problems, developmental delays, intellectual disability, genetic testing, gene therapy.
Health & MedicineConditions Encyclopedia Entry 1782308645
Klinefelter Syndrome is a genetic condition affecting males, characterized by the presence of an extra X chromosome, leading to developmental, reproductive, and physical abnormalities.
Health & MedicineConditions Encyclopedia Entry 1778492647
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA. These disorders affect the mitochondria, the energy-producing structures within cells, leading to a range of symptoms and complications. MMs are characterized by progressive muscle weakness, fatigue, and other systemic symptoms. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning they can be passed down from one generation to the next through a mother's mitochondrial DNA. The symptoms of MMs can vary widely depending on the specific disorder and the individual affected. Common symptoms include muscle weakness, particularly in the arms and legs, as well as fatigue, exercise intolerance, and shortness of breath. Some individuals may also experience seizures, developmental delays, and other systemic symptoms. The disorders can affect individuals of any age, but they are often diagnosed in childhood or adolescence. ### History/Background The first reported cases of MMs date back to the 1960s, when researchers identified a group of individuals with a rare disorder characterized by progressive muscle weakness and fatigue. Since then, numerous studies have identified several different types of MMs, each caused by distinct mutations in the mitochondrial DNA. In the 1980s, researchers developed techniques for diagnosing MMs using muscle biopsy and DNA analysis. Today, MMs are recognized as a distinct group of disorders, with several different types and subtypes. ### Key Information There are several different types of MMs, each caused by distinct mutations in the mitochondrial DNA. Some of the most common types include: * **Kearns-Sayre Syndrome**: a rare disorder characterized by progressive muscle weakness, fatigue, and other systemic symptoms. * **Myoclonic Epilepsy with Ragged-Red Fibers**: a disorder characterized by seizures, muscle weakness, and other systemic symptoms. * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes**: a disorder characterized by seizures, muscle weakness, and other systemic symptoms. Individuals with MMs often experience a range of complications, including muscle weakness, fatigue, and other systemic symptoms. In some cases, the disorders can lead to life-threatening complications, such as respiratory failure or cardiac arrest. ### Significance Mitochondrial Myopathies are a significant public health concern, affecting thousands of individuals worldwide. The disorders are often diagnosed in childhood or adolescence, and they can have a profound impact on an individual's quality of life. While there is no cure for MMs, researchers are working to develop new treatments and therapies to manage the symptoms and complications of these disorders. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, genetic disorder, mitochondrial DNA, muscle weakness, fatigue, exercise intolerance, seizures, developmental delays, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. **When to Seek Professional Care:** If you or a family member is experiencing symptoms of Mitochondrial Myopathies, seek medical attention immediately. Early diagnosis and treatment can help manage the symptoms and complications of these disorders. Consult a healthcare professional or a genetic counselor for more information.